Emerging non-D2 receptor-based therapies for schizophrenia: a focus on muscarinic and glutamatergic pathways - Quiz - MDSpire

Emerging non-D2 receptor-based therapies for schizophrenia: a focus on muscarinic and glutamatergic pathways

  • By

  • Yunxiang Wang

  • Jiajia Wang

  • Xiao Zhang

  • Xudong Liu

  • July 10, 2026

  • 0 min

Share

Original Source(s)

Emerging non-D2 receptor-based therapies for schizophrenia: a focus on muscarinic and glutamatergic pathways

  • by Yunxiang Wang, Jiajia Wang, Xiao Zhang, Xudong Liu

  • July 10, 2026

Related Content

Exploring the influencing factors of initial seizure time during modified electroconvulsive therapy in patients under 30 years old with mental disorders

Quantitative electroencephalography as a potential neurophysiological diagnostic biomarker of schizophrenia and first-episode psychosis: a systematic review of clinical implications

An interpretable TimeMIL framework for fNIRS: differential diagnosis between schizophrenia and bipolar disorder